Pennsylvania’s Supreme Court has declined to consider a novel theory that a plaintiff may show a drugmaker failed to warn of all risks from its drug, rather than directly showing the drugmaker failed to warn of the specific harm that ultimately caused the plaintiff’s injury.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *